Nucleoside transporters in the purinome.
The purinome is a rich complex of proteins and cofactors that are involved in fundamental aspects of cellular homeostasis and cellular responses. The purinome is evolutionarily ancient and is made up of thousands of members. Our understanding of the mechanisms linking some parts of this complex network and the physiological relevance of the various connections is well advanced. However, our understanding of other parts of the purinome is less well developed. Our research focuses on the adenosine or nucleoside transporters (NTs), which are members of the membrane purinome. Nucleoside transporters are integral membrane proteins that are responsible for the flux of nucleosides, such as adenosine, and nucleoside analog drugs, used in a variety of anti-cancer, anti-viral and anti-parasite therapies, across cell membranes. Nucleoside transporters form the SLC28 and SLC29 families of solute carriers and the protein members of these families are widely distributed in human tissues including the central nervous system (CNS). NTs modulate purinergic signaling in the CNS primarily through their effects on modulating prevailing adenosine levels inside and outside the cell. By clearing the extracellular milieu of adenosine, NTs can terminate adenosine receptor-dependent signaling and this raises the possibility of regulatory feedback loops that tie together receptor signaling with transporter function. Despite the important role of NTs as modulators of purinergic signaling in the human body, very little is known about the nature or underlying mechanisms of regulation of either the SLC28 or SLC29 families, particularly within the context of the CNS purinome. Here we provide a brief overview of our current understanding of the regulation of members of the SLC29 family and highlight some interesting avenues for future research.
Department of Biology, Faculty of Science, York University, Toronto, ON, Canada.
Alexandre
A
Dos Santos-Rodrigues
Department of Chemistry and Biology, Faculty of Science, Ryerson University, Toronto, ON, Canada.
Natalia
N
Grañé-Boladeras
Department of Biology, Faculty of Science, York University, Toronto, ON, Canada.
Alex
A
Bicket
Department of Biology, Faculty of Science, York University, Toronto, ON, Canada; Department of Chemistry and Biology, Faculty of Science, Ryerson University, Toronto, ON, Canada. Electronic address: imogen.coe@ryerson.ca.
Imogen R
IR
Coe
D006801:Humans; D009422:Nervous System Diseases / Q000235:genetics / Q000503:physiopathology; D033703:Nucleoside Transport Proteins / Q000235:genetics / Q000502:physiology*; D011687:Purines / Q000378:metabolism*; D011983:Receptors, Purinergic / Q000235:genetics / Q000502:physiology
D033703:Nucleoside Transport Proteins; D011687:Purines; D011983:Receptors, Purinergic
Casein kinase II (CKII); Nucleoside transporters; Phosphorylation; Protein kinase A (PKA); Protein kinase C (PKC); Purinome; Receptors; Regulation; miRNAs